Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Liver Cancer
Interventions: Drug: iodinated contrast dye; Drug: motexafin gadolinium; Other: laboratory biomarker analysis
Sponsors: American College of Radiology Imaging Network; National Cancer Institute (NCI)
Not yet recruiting - verified March 2010
Condition: Liver Cancer
Interventions: Drug: temsirolimus; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: quality-of-life assessment; Radiation: fludeoxyglucose F 18
Sponsor: Federation Francophone de Cancerologie Digestive
Recruiting - verified March 2010
Conditions: Liver Fibrosis; Liver Cirrhosis; Viral Hepatitis; Liver Tumour; Cardiac Failure; Biliary Cholestasis.
Interventions: Device: ARFI measurement; Device: ARFI measurement; Device: ARFI measurement
Sponsor: University Hospital, Bordeaux
Not yet recruiting - verified March 2010
Condition: Hepatocellular Carcinoma
Intervention: Drug: Adjuvant group
Sponsor: Yonsei University
Completed - verified January 2009
Condition: Liver Cancer
Interventions: Drug: pravastatin; Drug: sorafenib tosylate; Other: laboratory biomarker analysis; Other: pharmacogenomic studies; Procedure: quality-of-life assessment
Sponsor: Federation Francophone de Cancerologie Digestive
Recruiting - verified February 2010
Condition: Carcinoma, Hepatocellular
Intervention: Device: Ablation with the NanoKnife Irreversible Electroporation (IRE) System
Sponsor: Angiodynamics, Inc.
Recruiting - verified March 2010
Condition: Liver Cancer
Intervention: Device: Theraspheres
Sponsors: Stanford University; MDS Nordion, Inc.
Available - verified February 2010
Conditions: Head and Neck Cancer; Lung Cancer; Liver Cancer; Rectal Cancer; Cervical Cancer
Intervention: Drug: [F 18]HX4
Sponsor: Siemens Molecular Imaging
Recruiting - verified February 2010
Condition: Liver Cancer
Interventions: Drug: sorafenib tosylate; Drug: vorinostat
Sponsors: Virginia Commonwealth University; Massey Cancer Center
Not yet recruiting - verified March 2010
Condition: Hepatocellular Cancer
Intervention:
Sponsor: Sydney West Area Health Service
Recruiting - verified February 2010
Conditions: Hepatic Metastases; Colorectal Cancer
Intervention: Procedure: Routine hilar lymphadenectomy
Sponsor: University of Heidelberg
Enrolling by invitation - verified February 2010
Condition: Transfusional Hemosiderosis in Sickle Cell Disease
Intervention: Drug: ICL670
Sponsor: Novartis Pharmaceuticals
Completed - verified March 2010
Condition: HIV-1 Infections
Intervention:
Sponsors: Merck; EuroSIDA Coordinating Centre, Copenhagen HIV Programme (CHIP)
Active, not recruiting - verified February 2010
Conditions: Acute on Chronic Liver Failure; Hepatitis B
Intervention: Drug: Tenofovir disoproxil fumarate (TDF)
Sponsor: Govind Ballabh Pant Hospital
Completed - verified October 2009
All Categories ... Medical Conditions » ... Cancers » ... Liver Cancer 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
